Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDER personnel moves

This article was originally published in The Tan Sheet

Executive Summary

GlaxoSmithKline NeuroHealth Specialty Division VP Shirley Murphy, MD, will become first director of FDA's Division of Pediatric Drug Development effective Sept. 9. Prior to joining GSK, Murphy was at the University of New Mexico, where she headed the Division of Pulmonary Medicine and chaired the Department of Pediatrics. She also is a previous chair of FDA's Pulmonary-Allergy Drugs Advisory Committee. Also, Victor Raczkowski, MD, will take over as Office of Drug Safety director Sept. 9. Raczkowski is currently ODE III deputy director and acting head of the Division of Gastrointestinal & Coagulation Drug Products. He participated in the June advisory committee review of AstraZeneca/P&G's OTC switch application for Prilosec 1...

You may also be interested in...

Amgen/AstraZeneca’s Tezepelumab Cuts Asthma Exacerbations By 56%

Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics. 

Sarepta’s Next-Generation Drugs Draw Attention Amid ‘Incremental’ Approval

The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.

COVID-19 Will Forever Change Workplace, But Not Necessarily For The Better, Merck’s Frazier Says

Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts